LADENBURG THALMANN FINANCIAL SERVICES INC. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2019$205,000
+54.1%
7,402
+1.4%
0.00%0.0%
Q3 2019$133,000
-29.6%
7,300
-5.2%
0.00%0.0%
Q2 2019$189,000
+195.3%
7,700
+14.9%
0.00%
Q1 2019$64,000
+1.6%
6,700
-6.5%
0.00%
-100.0%
Q4 2018$63,000
-31.5%
7,168
-12.2%
0.00%0.0%
Q3 2018$92,000
-4.2%
8,168
+43.3%
0.00%0.0%
Q2 2018$96,0000.0%5,7000.0%0.00%0.0%
Q1 2018$96,000
+380.0%
5,700
+135.1%
0.00%
Q4 2017$20,000
+11.1%
2,425
+9.0%
0.00%
Q3 2017$18,000
+5.9%
2,2250.0%0.00%
Q2 2017$17,0002,2250.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MHR Fund Management 19,997,103$90,986,81911.15%
MPM BioImpact LLC 3,287,397$14,957,6563.99%
Perceptive Advisors 11,962,938$54,431,3671.82%
CM Management, LLC 200,000$910,0000.97%
Velan Capital Investment Management LP 250,000$1,137,5000.92%
Opaleye Management Inc. 610,000$2,775,5000.90%
Boxer Capital, LLC 3,705,133$16,858,3550.90%
SECTORAL ASSET MANAGEMENT INC 985,000$4,481,7500.87%
Parametrica Management Ltd 95,400$434,0700.73%
683 Capital Management, LLC 2,050,000$9,327,5010.72%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders